Nevertheless, one specific IGF-binding protein known to be produced in excess by some tumour types (e.g. colorectum, prostate) is IGFBP-2, and this may lead to some increase in circulating levels (which are much lower than those of IGF-I and IGFBP-3). This evidence concerns the gene IGFBP2 and neoplasm.